ResearchMoz.us

ResearchMoz is the one stop online destination to find and buy market research reports and Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Sunday, 26 April 2015

Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market 2015

Posted on 23:51 by Unknown
ResearchMoz.us include new market research report"Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market 2015 " to its huge collection of research reports.

This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by over 270 tables & figures over 254 pages. The personalized medicine (global) market is presented as follows:


By Company (e.g., 23andMe, AFFYMETRIX, ATOSSA GENETICS, NODALITY, deCode /Amgen, CELERA, MYRIAD)
By Geography (US, UK, EU)
By Segment (Targeted therapeutics, Companion Diagnostics, Esoteric tests, Esoteric lab services)
By Sub-market (Companion diagnostics & therapeutic, nutrition & wellness, medical technology, pharmacogenomics, consumer genomics)


A wealth of financial data & business strategy information is provided including:

Company financials, sales & revenue figures
Business Model Strategies for Diagnostic, Pharmaceutical and Biotechnology Companies
Business Model Strategies for Providers. Provider Systems and Academic Medical Centres
Business Model Strategies for Payers & Governments
Private and Public Funding and Personalized Medicine Reimbursement
Revisions to Current Payment Systems and intellectual property
How to Gain Market Penetration in the EU
Cost-effectiveness and Business Value of Personalized Medicine
Consumer genomics and POC market
Therapeutics and Companion Diagnostics (e.g., BRAC Analysis, Oncotype Dx , KRAS Mutations)
Comprehensive account of company product portfolios & kits


All Latest Market Research Report @ http://www.researchmoz.us/latest-report.html

SWOT, Economic & Regulatory Environment specifics include:

Key strengths, weaknesses and threats influencing leading player position within the market
Technologies driving the market (e.g., New-Generation Sequencing Technologies, Ultra-High Throughput Sequencing)
Top fastest growing market segments and emerging opportunities
Top pharmaceutical companies within the IPM by market share and revenue
Comprehensive product portfolios, R&D activity and pipeline therapeutics
M&A activity and future strategies of top personalized medicine pharmacos
Personalized Medicine Regulation (USA, UK, Germany, France, Spain, Italy)
CE-marked Personalized Medicine/Diagnostic Tests
FDA Advances in Personalized Medicine Regulation


This report highlights a number of significant pharmacos and gives details of their operations, products, financials and business strategy.

23andMe
Affymetrix
Astex Pharmaceuticals
Atossa Genetics
CuraGen
Celera Corporation (Quest Diagnostics)
Celldex Therapeutics
deCode Genetics (Amgen)
Illumina
Genelex
Myriad
Nodality
Qiagen 

What you will gain:

An in-depth understanding of the global personalized medicine market and it’s environment
Current market facts, figures and product lines of key players in the industry
Emerging trends in key markets such as the US, UK, Germany and France
Knowledge of how the personalized medicine market will integrate into the global healthcare market
Technical insights into new generation sequencing technologies and ultra-high throughput sequencing
Updates on bioinformatics, high throughput systems, genetic analysis kits, companion diagnostics and future technologies
FDA approved pharmacogenetic tests and recognized biomarkers
Information on key government and regulatory policies
Strategies on how to adapt and restructure current business models to this industry

All Countrywise Report @ http://www.researchmoz.us/country.html

This report tackles key concerns to the personalized medicine market such as:

Lack of regulatory policy and legislation in the US and Europe
Reimbursement schemes and payers concerns
Transition of investigational diagnostic assays and therapeutics to clinical practice
Direct to consumer (DTC) test kits and implications for the public


Who should read this report?

Pharmaceutical, biotechnology and diagnostic companies with an interest in personalized medicine
Industry professionals and business strategists will discover key information to propel their policies
Investors will gain inside information to dominant players in the industry and future forecasts
Scientists will get a business perspective and industry insight into how scientific breakthroughs influence the market environment


This report will tell you if the companies mentioned are:

Strong, competitive players
Pooling their resources for specific growth and therapeutic areas
Investing strategically in R&D
Have a history of strategic M&A activity


This detailed report is supported with 263 figures and tables over 224 pages and profiles the main pharmacos in personalized medicine.

For More Information Kindly Contact:
Email: sales@researchmoz.us 
Posted in , | No comments

0 comments:

Post a Comment

Subscribe to: Post Comments (Atom)